Terns Pharmaceuticals, Inc.
TERN
$2.92
-$0.13-4.26%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.67% | 3.48% | -1.62% | -6.44% | 29.39% |
| Total Depreciation and Amortization | 3.88% | -14.17% | 1.69% | 7.27% | -0.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -57.47% | 7.69% | 5.05% | 125.18% | -86.71% |
| Change in Net Operating Assets | 376.28% | -54.86% | 155.65% | -2,609.94% | 95.43% |
| Cash from Operations | 11.37% | -1.71% | 29.03% | -18.03% | 6.68% |
| Capital Expenditure | -- | 100.00% | 55.17% | 34.09% | -450.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -397.16% | -24.77% | 425.84% | -83.02% | 311.95% |
| Cash from Investing | -397.16% | -24.75% | 427.59% | -83.07% | 311.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.62% | 40,844.11% | -- | -- | 69,210.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -317.33% | -- | -- | -- | -- |
| Cash from Financing | -99.81% | 40,825.31% | -- | -- | 69,210.00% |
| Foreign Exchange rate Adjustments | -230.19% | 478.57% | 46.15% | -110.20% | 850.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -160.85% | 576.74% | 278.03% | -135.27% | 197.69% |